Show simple item record

dc.contributor.authorChernew, Michael E.
dc.contributor.authorRosen, Allison B.
dc.contributor.authorFendrick, A. Mark
dc.date2022-08-11T08:10:44.000
dc.date.accessioned2022-08-23T17:18:08Z
dc.date.available2022-08-23T17:18:08Z
dc.date.issued2006-03-10
dc.date.submitted2011-01-14
dc.identifier.citationAm J Manag Care. 2006 Mar;12(3):150-4.
dc.identifier.issn1088-0224 (Linking)
dc.identifier.pmid16524347
dc.identifier.urihttp://hdl.handle.net/20.500.14038/47787
dc.description.abstractOBJECTIVES: To document the rise in copayments for patients in disease management programs and to call attention to the inherent conflicts that exist between these 2 approaches to benefit design. METHODS: Data from 2 large health plans were used to compare cost sharing in disease management programs with cost sharing outside of disease management programs. RESULTS: The copayments charged to participants in disease management programs usually do not differ substantially from those charged to other beneficiaries. CONCLUSIONS: Cost sharing and disease management result in conflicting approaches to benefit design. Increasing copayments may lead to underuse of recommended services, thereby decreasing the clinical effectiveness and increasing the overall costs of disease management programs. Policymakers and private purchasers should consider the use of targeted benefit designs when implementing disease management programs or redesigning cost-sharing provisions. Current information systems and health services research are sufficiently advanced to permit these benefit designs.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=16524347&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://www.ajmc.com/issue/managed-care/2006/2006-03-vol12-n3/Mar06-2260p150-154
dc.subjectCost Sharing
dc.subject*Disease Management
dc.subjectHumans
dc.subjectManaged Care Programs
dc.subjectUnited States
dc.subjectBiostatistics
dc.subjectEpidemiology
dc.subjectHealth Services Research
dc.titleRising out-of-pocket costs in disease management programs
dc.typeJournal Article
dc.source.journaltitleThe American journal of managed care
dc.source.volume12
dc.source.issue3
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/qhs_pp/904
dc.identifier.contextkey1729439
html.description.abstract<p>OBJECTIVES: To document the rise in copayments for patients in disease management programs and to call attention to the inherent conflicts that exist between these 2 approaches to benefit design.</p> <p>METHODS: Data from 2 large health plans were used to compare cost sharing in disease management programs with cost sharing outside of disease management programs.</p> <p>RESULTS: The copayments charged to participants in disease management programs usually do not differ substantially from those charged to other beneficiaries.</p> <p>CONCLUSIONS: Cost sharing and disease management result in conflicting approaches to benefit design. Increasing copayments may lead to underuse of recommended services, thereby decreasing the clinical effectiveness and increasing the overall costs of disease management programs. Policymakers and private purchasers should consider the use of targeted benefit designs when implementing disease management programs or redesigning cost-sharing provisions. Current information systems and health services research are sufficiently advanced to permit these benefit designs.</p>
dc.identifier.submissionpathqhs_pp/904
dc.contributor.departmentDepartment of Quantitative Health Sciences
dc.source.pages150-4


This item appears in the following Collection(s)

Show simple item record